300 soldiers vaccinated in Isabela province | Inquirer News

300 soldiers vaccinated in Isabela province

By: - Correspondent / @VillVisayaJrINQ
/ 05:38 PM March 17, 2021

CAMP MELCHOR DELA CRUZ, Isabela –– At least 300 Army soldiers were inoculated with the CoronaVac vaccines inside the military camp of the 5th Infantry Division here on Tuesday.

A total of 600 doses of the Chinese brand of vaccines were given to medical frontliners and government troops that are assigned to coronavirus disease (COVID-19) checkpoints in the province, according to Brig. Gen. Larry Mojica, 5th Infantry Division assistant division commander.

To encourage fellow soldiers, Mojica volunteered to get vaccinated first. Capt. Cherry Lynne Imee Hopdayan, 5ID Station Hospital chief nurse, administered the jab.

Article continues after this advertisement

“No negative issues will stop me from being vaccinated. I am happy that there is a vaccine now. There is nothing to worry about this vaccine. We should be thankful that we can effectively perform our jobs with this protection,” Mojica said during the ceremonial vaccination.

FEATURED STORIES

Col. Ferdinand Melchor Dela Cruz, 5th ID chief of staff, was also among those who got the vaccines manufactured by Sinovac Biotech Ltd.

Lt. Col. William Joseph Rigor, 5ID Station Hospital commander, said more doses of SinoVac intended for the Army soldiers are expected to arrive here.

Edited by LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Isabela

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.